Gayatri Balan, Bellevue, WA (US); Mark J. Bartlett, Castro Valley, CA (US); Jayaraman Chandrasekhar, Redmond, WA (US); Julian A Codelli, Mountlake Terrace, WA (US); John H. Conway, Somerville, MA (US); Jennifer L Cosman Ellis, Foster City, CA (US); Rao V. Kalla, Foster City, CA (US); Zachary A Kasun, Seattle, WA (US); Musong Kim, Bellevue, WA (US); Seung H. Lee, Sammamish, WA (US); Jennifer R. Lo, Seattle, WA (US); Jennifer A. Loyer-Drew, Seattle, WA (US); Scott A. Mitchell, Kenmore, WA (US); Thao D. Perry, San Jose, CA (US); Gary B. Phillips, Issaquah, WA (US); Patrick J. Salvo, Burien, WA (US); Sundaramoorthi Swaminathan, Burlingame, CA (US); Joshua J. Van Veldhuizen, Seattle, WA (US); Suet C. Yeung, Redmond, WA (US); and Jeff Zablocki, Los Altos, CA (US)
Assigned to Gilead Sciences, Inc., Foster City, CA (US)
Filed by Gilead Sciences, Inc., Foster City, CA (US)
Filed on Dec. 18, 2023, as Appl. No. 18/543,272.
Application 18/543,272 is a continuation of application No. 17/522,628, filed on Nov. 9, 2021, granted, now 11,897,878.
Application 17/522,628 is a continuation of application No. 16/669,346, filed on Oct. 30, 2019, granted, now 11,203,591.
Claims priority of provisional application 62/868,550, filed on Jun. 28, 2019.
Claims priority of provisional application 62/753,339, filed on Oct. 31, 2018.
Prior Publication US 2024/0287061 A1, Aug. 29, 2024
